Aprinoia Therapeutics (Aprinoia Therapeutics) Other Stockholders Equity : $-0.00 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Other Stockholders Equity?

Aprinoia Therapeutics's Other Stockholders Equity for the quarter that ended in Jun. 2023 was $-0.00 Mil.

Aprinoia Therapeutics's quarterly Other Stockholders Equity stayed the same from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then declined from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($-0.00 Mil).

Aprinoia Therapeutics's annual Other Stockholders Equity increased from . 20 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) and increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.00 Mil).

Aprinoia Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Aprinoia Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Other Stockholders Equity Chart

Aprinoia Therapeutics Annual Data

Trend

Dec21

Dec22

Other Stockholders Equity

Aprinoia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23
Other Stockholders Equity	-	-	-	-

Aprinoia Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Aprinoia Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines